To determine whether reprogramming the fate of glioma cells has any therapeutic potential for brain tumors, we examined the effect of ectopic expression of NGN2/SOX11 on the growth of preexisting tumors (Figure 6a). Here, NEUROG2 is linked to central nervous system cancer.